Sort   by:  
 Page size 
UnknownPhase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia.
Not available
S-EPMC5477824 | biostudies-literature
UnknownPhase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Not available
S-EPMC3158600 | biostudies-literature
UnknownMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Not available
S-EPMC3948096 | biostudies-literature
UnknownUtility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
Not available
S-EPMC4322260 | biostudies-literature
UnknownComparative analysis of different approaches to measure treatment response in acute myeloid leukemia.
Not available
S-EPMC3462046 | biostudies-literature
TranscriptomicsHigh-Resolution Genomic Profiling of Adult and Pediatric Core-Binding-Factor Acute Myeloid Leukemia Reveals New Recurrent Genomic Alterations
To identify cooperating lesions in core-binding-factor acute myeloid leukemia (CBF-AML), we performed single-nucleotide polymorphism (SNP)-array analysis on 300 diagnostic and 41 relapse adult and pediatric leukemia samples. We identified a mean of 1.28 copy number alterations (CNAs) per case at dia...
ORGANISM(S): Homo sapiens 
2012-02-07 | E-GEOD-32462 | biostudies-arrayexpress
GenomicsWhole Genome Sequencing of Pediatric Acute Megakaryoblastic Leukemia

We have performed whole genome sequencing of 4 cases of pediatric acute megakaryoblastic leukemia to identify somatic genetic alterations driving leukemogenesis.

phs000413.v1.p1 | EGA
Sort   by:  
 Page size